微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 30.66% | 17.2% | 2.65% | 113/159 | 32.3% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 29.87% | -48.39% | 16.27% | 121/159 | 51.8% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 25.69% | -63.17% | 4.63% | 129/159 | 22.98% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 24.55% | -67.45% | -6.15% | 134/159 | 33.39% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 26.16% | -68.38% | -54.8% | 126/159 | 51.73% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 57.88% | -3.72% | -17.02% | 63/159 | 51.53% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 69.75% | 52.16% | -7.53% | 35/159 | 32.76% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 75.43% | 87.49% | -8.84% | 29/159 | 38.65% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 82.74% | 87.64% | 37.63% | 18/159 | 52.91% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 60.11% | 58.55% | 31.15% | 58/159 | 53.74% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 45.84% | 17.1% | 13.94% | 87/159 | 6.69% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 40.23% | -0.69% | -8.76% | 100/159 | 21.74% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 44.09% | 2% | 16.29% | 86/159 | 54.47% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 37.92% | -11% | -3.14% | 112/159 | 55.21% | 首药控股 | 99.93% | 行业排名> |
| 2021-09-30 | 39.14% | 2% | -3.37% | 98/159 | 47.01% | 艾力斯 | 99.41% | 行业排名> |
| 2021-06-30 | 40.51% | -5.98% | -4.91% | 98/159 | 47.45% | 艾力斯 | 98.7% | 行业排名> |
| 2020-12-31 | 42.6% | 3.48% | -1.12% | 101/159 | -144.37% | 艾力斯 | 99.4% | 行业排名> |
| 2020-06-30 | 43.08% | 12.93% | 4.65% | 90/159 | 54.32% | 首药控股 | 99.94% | 行业排名> |
| 2019-12-31 | 41.17% | -9.26% | -9.26% | 98/159 | -1213.38% | 泽璟制药 | 99.96% | 行业排名> |
| 2018-12-31 | 45.37% | 49.25% | 18.93% | 80/159 | -205.91% | 微芯生物 | 95.14% | 行业排名> |
| 2018-06-30 | 38.15% | 48.19% | 25.49% | 80/159 | 53.68% | 多瑞医药 | 95.59% | 行业排名> |
| 2017-12-31 | 30.4% | 32.84% | 18.08% | 104/159 | 52.58% | 微芯生物 | 95.81% | 行业排名> |
| 2017-06-30 | 25.74% | 2% | 12.49% | 91/159 | 48.02% | 微芯生物 | 96.09% | 行业排名> |
| 2016-12-31 | 22.88% | 2% | 2% | 105/159 | 48.44% | 微芯生物 | 96.11% | 行业排名> |